(OCT4, 19%; SOX2, 29%; NANOG, 14%; LIN28A, 9%; KLF4, 29%); the SOX2 and KLF4 genes were amplified predominantly in prostate cancer (Fig. 3d, upper panel). Here, SOX2 is linked to prostate carcinoma.